2021
DOI: 10.1016/j.bbi.2021.02.031
|View full text |Cite
|
Sign up to set email alerts
|

Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 35 publications
0
12
0
2
Order By: Relevance
“…Such immune markers, constituting an extensive number of cytokines and adhesion molecules ( Kroken et al, 2018 ), are involved in complex interacting immune regulatory mechanisms, potentially related to the increased cardiovascular disease risk in SMDs ( De Hert et al, 2018 ; Reponen et al, 2020 ). Determinants of immune marker levels are mainly unknown, although a major impact of non-heritable factors is indicated ( Brodin et al, 2015 ), in particular acquired metabolic disturbances ( Huet et al, 2021 ; Makki et al, 2013 ), and interactions with endocrine systems ( Taub, 2008 ). However, as studies of systemic immune abnormalities in SMDs are based on individual markers ( Dickerson et al, 2016 ; Kroken et al, 2018 ), common underlying mechanisms have been challenging to uncover, and findings are prone to spurious variation.…”
Section: Introductionmentioning
confidence: 99%
“…Such immune markers, constituting an extensive number of cytokines and adhesion molecules ( Kroken et al, 2018 ), are involved in complex interacting immune regulatory mechanisms, potentially related to the increased cardiovascular disease risk in SMDs ( De Hert et al, 2018 ; Reponen et al, 2020 ). Determinants of immune marker levels are mainly unknown, although a major impact of non-heritable factors is indicated ( Brodin et al, 2015 ), in particular acquired metabolic disturbances ( Huet et al, 2021 ; Makki et al, 2013 ), and interactions with endocrine systems ( Taub, 2008 ). However, as studies of systemic immune abnormalities in SMDs are based on individual markers ( Dickerson et al, 2016 ; Kroken et al, 2018 ), common underlying mechanisms have been challenging to uncover, and findings are prone to spurious variation.…”
Section: Introductionmentioning
confidence: 99%
“…A study of COVID-19 survivors one month after hospital discharge found that increased BMI was associated with higher odds of persistence of fatigue [ 42 ]. Fatigue is associated with greater fat mass [ 43 ], both overweight and obese subjects showed higher fatigue scores compared to normal weight participants, and might be related to systemic inflammation [ 44 ]. Housewives are less affected by pandemic compared to the working population.…”
Section: Discussionmentioning
confidence: 99%
“…Precision medicine aims to identify target groups based on clinical and/or biological factors, who may benefit from specific treatments. This approach has been successfully used in the past for other psychiatric conditions ( Raison et al, 2013 ; Huet et al, 2021 ; Cussotto et al, 2022 ), but has only rarely been used for outcomes of RCTs with schizophrenia patients: Martinuzzi et al (2019) successfully stratified a large number of first episode psychosis patients using the PANSS score in a clinical trial with amisulpride and Weiser pre-selected patients using a cut-off value of CRP in a trial with aspirin ( Weiser et al, 2021 ). Interestingly, post-hoc associations in the first episode psychosis patients did reveal an association of one cluster with higher levels of inflammatory markers ( Martinuzzi et al, 2019 ), but the study of Weiser and colleagues failed to show a significant effect of aspirin in the pre-selected patients.…”
Section: Discussionmentioning
confidence: 99%